Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients - A Subanalysis of the ENVISAGE-TAVI AF Trial.
Watanabe Y, Hayashida K, Yamamoto M, Yamanaka F, Yamasaki K, Naganuma T, Ohno Y, Yamawaki M, Morioka N, Mizutani K, Tada N, Ueno H, Nishina H, Izumo M, Nakajima Y, Ando K, Takagi K, Kimura T, Sugio K, Dangas G, Van Mieghem NM, Hengstenberg C, Chen C, Jin J, Unverdorben M, Saito S.
Watanabe Y, et al. Among authors: kimura t.
Circ J. 2022 Oct 25;86(11):1756-1763. doi: 10.1253/circj.CJ-22-0093. Epub 2022 Aug 11.
Circ J. 2022.
PMID: 35965066
Free article.
Clinical Trial.